The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report)'s stock price passed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $234.55 and traded as high as $241.97. Monarch Cement shares last traded at $241.50, with a volume of 518 shares changing hands. Monarch
The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totaling 232 shares, a growth of 42.3% from the December 31st total of 163 shares. Currently, 0.0% of the company's shares are short sold. Based on
Shares of The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report) were up 3.6% on Friday. The stock traded as high as $235.00 and last traded at $232.01. Approximately 699 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 1,584 shares. The stock had previously closed at
Shares of The Monarch Cement Co. (OTCMKTS:MCEM - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $232.24 and traded as low as $213.75. Monarch Cement shares last traded at $219.50, with a volume of 3,736 shares trading hands. Monarch Cement Stock
The Monarch Cement Company remains a 'Buy' despite recent share weakness and challenging market conditions, supported by a strong balance sheet and undervaluation. MCEM's Q3 2025 saw revenue and profitability decline due to broader economic headwinds, particularly in Ready-Mixed Concrete, but the Cement Business showed resilience. Compared to peers, MCEM is the cheapest based on earnings and cash flow multiples, with a lower risk profile due to its debt-free status and substantial cash reserves.
MCEM posts lower Q3 revenues and profit as ready-mix volumes drop, margins tighten, and market conditions soften amid weather and portfolio shifts.
Despite recent underperformance, Monarch Cement remains a "Buy" due to its strong long-term outperformance versus the S&P 500 and solid balance sheet. Recent revenue and cash flow declines are disappointing, but the company's debt-free status and significant net cash provide financial flexibility. Industry-wide demand for cement is down due to macroeconomic headwinds, but Monarch's valuation remains attractive compared to peers on multiple metrics.
MCEM's Q2 earnings rise y/y on higher profits from investments, but revenues fall on weaker concrete sales and margin pressure.
MCEM posts sharp Q1 earnings drop as bad weather hits sales and investment losses weigh on earnings despite solid margins and strong liquidity.
Despite recent financial weakness, The Monarch Cement Company remains a 'buy' due to its attractive valuation and strong balance sheet with no debt and significant cash reserves. The company's revenue and net income dropped significantly in Q1 2025, largely due to inclement weather and volatility in its equity portfolio. Compared to similar firms, Monarch Cement is undervalued, offering potential upside of 13.2% to 101.6% if it trades at peer multiples.
MCEM sales rise 2% y/y in 2024, but net income falls 10.4% as cost pressures and lower volumes impact profitability.
The Monarch Cement Company has shown strong performance, with shares up 15.8% since August 2024 and 50.7% since December 2023, outperforming the S&P 500. Despite significant growth, the stock remains attractive due to robust revenue, profit, and cash flow growth, supported by a strong balance sheet with no debt. The cement industry is expected to grow, driven by increased construction starts, with Monarch Cement's revenue and profitability metrics showing consistent improvement.
MCEM posts robust Q3 results with higher sales, improved EPS and significant equity gains, outperforming the market by a wide margin.
Monarch Cement has a strong track record, high returns on capital, and prudent management, but faces challenges from industry cyclicality and regulatory risks. Financials show sustainable revenue growth and high returns on capital, but EPS is distorted by external investments, necessitating a cautious valuation approach. Despite its strengths, the cyclical nature of the industry and regulatory risks lead me to recommend a "Hold" for long-term stability.
A decrease in sales from the Cement and Ready-Mixed Concrete segments hurt Monarch Cement's (MCEM) earnings in Q2.
The Monarch Cement Company is a healthy, growing business with a net cash position and that's trading at a discount. First quarter results show significant revenue growth, particularly in the ready mixed concrete business, though recently reported second quarter results were less impressive. The company's strong balance sheet, lack of debt, and cheap valuation make it a compelling investment with a 'strong buy' rating.
The IIJA (Infrastructure Investment and Jobs Act) is a $1.2 trillion investment over a five-year period.
Discover why Zacks rates Monarch Cement (MCEM) as " Outperform," being the first on Wall Street to initiate the coverage of the stock. Explore MCEM's strategic market presence and growth prospects from the Infrastructure Investment and Jobs Act amid rising costs and regulatory challenges.
The Monarch Cement Company has performed well, outpacing the S&P 500 with a 17.4% increase in share price in recent months. The company's revenue and profits have been consistently growing, driven by higher sales prices and increased volumes. MCEM stock is undervalued and has the potential for significant upside, especially considering the expected growth in the cement industry.
Monarch Cement is a small company with a market capitalization of $583 million that may be overlooked by investors. The company produces and sells Portland cement, primarily used in the production of ready-mixed concrete. Despite economic concerns, Monarch Cement has achieved growth in revenue and profits, making it a solid investment opportunity.